Novian Health & UCSD are enrolling patients for the Novilase trial to treat early-stage breast cancer with laser ablation. A game-changer for less invasive care! 🤝 Learn more: https://t.co/FjbC51bjpC. #BreastCancerResearch#MedicalInnovation
.@NovianHealth receives FDA Breakthrough Device designation for @Novilase device for minimally-invasive focal destruction malignant breast tumors in adult women desiring a breast conserving procedure. Read more:https://t.co/hg00wpJVRr #breastcancer#BreastCancerAwarenessMonth